Split-dose preparation for colonoscopy increases adenoma detection rate

A randomised controlled trial in an organised screening programme

F. Radaelli, S. Paggi, C. Hassan, C. Senore, R. Fasoli, A. Anderloni, F. Buffoli, M. F. Savarese, G. Spinzi, Douglas Rex, A. Repici

Research output: Contribution to journalArticle

36 Citations (Scopus)

Abstract

Objective Although a split regimen of bowel preparation has been associated with higher levels of bowel cleansing, it is still uncertain whether it has a favourable effect on the adenoma detection rate (ADR). The present study was aimed at evaluating whether a split regimen was superior to the traditional 'full-dose, day-before' regimen in terms of ADR. Design In a multicentre, randomised, endoscopistblinded study, 50-69-year-old subjects undergoing first colonoscopy after positive-faecal immunochemical test within an organised colorectal cancer organised screening programmes were 1:1 randomised to receive low-volume 2-L polyethylene glycol (PEG)-ascorbate solution in a 'split-dose' (Split-Dose Group, SDG) or 'day-before' regimen (Day-Before Group, DBG). The primary endpoint was the proportion of subjects with at least one adenoma. Secondary endpoints were the detection rates of advanced adenomas and serrated lesions at per-patient analysis and the total number of lesions. Results 690 subjects were included in the study. At per-patient analysis, the proportion of subjects with at least one adenoma was significantly higher in the SDG than in the DBG (183/345, 53.0% vs 141/345, 40.9%, relative risk (RR) 1.22, 95% CI 1.03 to 1.46); corresponding figures for advanced adenomas were 26.4% (91/345) versus 20.0% (69/345, RR 1.35, 95% CI 1.06 to 1.73). At per-polyp analysis, the total numbers of both adenomas and advanced adenomas per subject were significantly higher in the SDG (1.15 vs 0.8, p

Original languageEnglish (US)
JournalGut
DOIs
StateAccepted/In press - Nov 9 2015

Fingerprint

Colonoscopy
Adenoma
Randomized Controlled Trials
Polyps
Early Detection of Cancer
Colorectal Neoplasms

ASJC Scopus subject areas

  • Gastroenterology

Cite this

Split-dose preparation for colonoscopy increases adenoma detection rate : A randomised controlled trial in an organised screening programme. / Radaelli, F.; Paggi, S.; Hassan, C.; Senore, C.; Fasoli, R.; Anderloni, A.; Buffoli, F.; Savarese, M. F.; Spinzi, G.; Rex, Douglas; Repici, A.

In: Gut, 09.11.2015.

Research output: Contribution to journalArticle

Radaelli, F, Paggi, S, Hassan, C, Senore, C, Fasoli, R, Anderloni, A, Buffoli, F, Savarese, MF, Spinzi, G, Rex, D & Repici, A 2015, 'Split-dose preparation for colonoscopy increases adenoma detection rate: A randomised controlled trial in an organised screening programme', Gut. https://doi.org/10.1136/gutjnl-2015-310685
Radaelli, F. ; Paggi, S. ; Hassan, C. ; Senore, C. ; Fasoli, R. ; Anderloni, A. ; Buffoli, F. ; Savarese, M. F. ; Spinzi, G. ; Rex, Douglas ; Repici, A. / Split-dose preparation for colonoscopy increases adenoma detection rate : A randomised controlled trial in an organised screening programme. In: Gut. 2015.
@article{fdae35829a0a400c977b7eae8e106a76,
title = "Split-dose preparation for colonoscopy increases adenoma detection rate: A randomised controlled trial in an organised screening programme",
abstract = "Objective Although a split regimen of bowel preparation has been associated with higher levels of bowel cleansing, it is still uncertain whether it has a favourable effect on the adenoma detection rate (ADR). The present study was aimed at evaluating whether a split regimen was superior to the traditional 'full-dose, day-before' regimen in terms of ADR. Design In a multicentre, randomised, endoscopistblinded study, 50-69-year-old subjects undergoing first colonoscopy after positive-faecal immunochemical test within an organised colorectal cancer organised screening programmes were 1:1 randomised to receive low-volume 2-L polyethylene glycol (PEG)-ascorbate solution in a 'split-dose' (Split-Dose Group, SDG) or 'day-before' regimen (Day-Before Group, DBG). The primary endpoint was the proportion of subjects with at least one adenoma. Secondary endpoints were the detection rates of advanced adenomas and serrated lesions at per-patient analysis and the total number of lesions. Results 690 subjects were included in the study. At per-patient analysis, the proportion of subjects with at least one adenoma was significantly higher in the SDG than in the DBG (183/345, 53.0{\%} vs 141/345, 40.9{\%}, relative risk (RR) 1.22, 95{\%} CI 1.03 to 1.46); corresponding figures for advanced adenomas were 26.4{\%} (91/345) versus 20.0{\%} (69/345, RR 1.35, 95{\%} CI 1.06 to 1.73). At per-polyp analysis, the total numbers of both adenomas and advanced adenomas per subject were significantly higher in the SDG (1.15 vs 0.8, p",
author = "F. Radaelli and S. Paggi and C. Hassan and C. Senore and R. Fasoli and A. Anderloni and F. Buffoli and Savarese, {M. F.} and G. Spinzi and Douglas Rex and A. Repici",
year = "2015",
month = "11",
day = "9",
doi = "10.1136/gutjnl-2015-310685",
language = "English (US)",
journal = "Gut",
issn = "0017-5749",
publisher = "BMJ Publishing Group",

}

TY - JOUR

T1 - Split-dose preparation for colonoscopy increases adenoma detection rate

T2 - A randomised controlled trial in an organised screening programme

AU - Radaelli, F.

AU - Paggi, S.

AU - Hassan, C.

AU - Senore, C.

AU - Fasoli, R.

AU - Anderloni, A.

AU - Buffoli, F.

AU - Savarese, M. F.

AU - Spinzi, G.

AU - Rex, Douglas

AU - Repici, A.

PY - 2015/11/9

Y1 - 2015/11/9

N2 - Objective Although a split regimen of bowel preparation has been associated with higher levels of bowel cleansing, it is still uncertain whether it has a favourable effect on the adenoma detection rate (ADR). The present study was aimed at evaluating whether a split regimen was superior to the traditional 'full-dose, day-before' regimen in terms of ADR. Design In a multicentre, randomised, endoscopistblinded study, 50-69-year-old subjects undergoing first colonoscopy after positive-faecal immunochemical test within an organised colorectal cancer organised screening programmes were 1:1 randomised to receive low-volume 2-L polyethylene glycol (PEG)-ascorbate solution in a 'split-dose' (Split-Dose Group, SDG) or 'day-before' regimen (Day-Before Group, DBG). The primary endpoint was the proportion of subjects with at least one adenoma. Secondary endpoints were the detection rates of advanced adenomas and serrated lesions at per-patient analysis and the total number of lesions. Results 690 subjects were included in the study. At per-patient analysis, the proportion of subjects with at least one adenoma was significantly higher in the SDG than in the DBG (183/345, 53.0% vs 141/345, 40.9%, relative risk (RR) 1.22, 95% CI 1.03 to 1.46); corresponding figures for advanced adenomas were 26.4% (91/345) versus 20.0% (69/345, RR 1.35, 95% CI 1.06 to 1.73). At per-polyp analysis, the total numbers of both adenomas and advanced adenomas per subject were significantly higher in the SDG (1.15 vs 0.8, p

AB - Objective Although a split regimen of bowel preparation has been associated with higher levels of bowel cleansing, it is still uncertain whether it has a favourable effect on the adenoma detection rate (ADR). The present study was aimed at evaluating whether a split regimen was superior to the traditional 'full-dose, day-before' regimen in terms of ADR. Design In a multicentre, randomised, endoscopistblinded study, 50-69-year-old subjects undergoing first colonoscopy after positive-faecal immunochemical test within an organised colorectal cancer organised screening programmes were 1:1 randomised to receive low-volume 2-L polyethylene glycol (PEG)-ascorbate solution in a 'split-dose' (Split-Dose Group, SDG) or 'day-before' regimen (Day-Before Group, DBG). The primary endpoint was the proportion of subjects with at least one adenoma. Secondary endpoints were the detection rates of advanced adenomas and serrated lesions at per-patient analysis and the total number of lesions. Results 690 subjects were included in the study. At per-patient analysis, the proportion of subjects with at least one adenoma was significantly higher in the SDG than in the DBG (183/345, 53.0% vs 141/345, 40.9%, relative risk (RR) 1.22, 95% CI 1.03 to 1.46); corresponding figures for advanced adenomas were 26.4% (91/345) versus 20.0% (69/345, RR 1.35, 95% CI 1.06 to 1.73). At per-polyp analysis, the total numbers of both adenomas and advanced adenomas per subject were significantly higher in the SDG (1.15 vs 0.8, p

UR - http://www.scopus.com/inward/record.url?scp=84954288952&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84954288952&partnerID=8YFLogxK

U2 - 10.1136/gutjnl-2015-310685

DO - 10.1136/gutjnl-2015-310685

M3 - Article

JO - Gut

JF - Gut

SN - 0017-5749

ER -